| Q61976265 | AAV for disorders of the CNS |
| Q36969314 | Coexpression of tyrosine hydroxylase, GTP cyclohydrolase I, aromatic amino acid decarboxylase, and vesicular monoamine transporter 2 from a helper virus-free herpes simplex virus type 1 vector supports high-level, long-term biochemical and behaviora |
| Q36969304 | Correction of a Rat Model of Parkinson's Disease by Coexpression of Tyrosine Hydroxylase and Aromatic Amino Acid Decarboxylase from a Helper Virus-Free Herpes Simplex Virus Type 1 Vector |
| Q45877347 | Double transduction with GTP cyclohydrolase I and tyrosine hydroxylase is necessary for spontaneous synthesis of L-DOPA by primary fibroblasts |
| Q34120723 | Encapsulated neural transplants |
| Q38378499 | Engineering Stem Cells for Biomedical Applications. |
| Q36012180 | Engraftment and migration of human bone marrow stromal cells implanted in the brains of albino rats--similarities to astrocyte grafts |
| Q37796024 | Gene therapy for dopamine replacement. |
| Q33837123 | Gene therapy in the CNS. |
| Q33614725 | Human nerual stem cells for brain repair |
| Q45859568 | Long-term clinical improvement in MPTP-lesioned primates after gene therapy with AAV-hAADC. |
| Q43535625 | Long-term restoration of striatal L-aromatic amino acid decarboxylase activity using recombinant adeno-associated viral vector gene transfer in a rodent model of Parkinson's disease |
| Q45856152 | Neurotrophin gene therapy in CNS models of trauma and degeneration |
| Q33567582 | Oocytes are a source of catecholamines in the primate ovary: evidence for a cell-cell regulatory loop |
| Q40115203 | Overexpression of lentivirus-mediated glial cell line-derived neurotrophic factor in bone marrow stromal cells and its neuroprotection for the PC12 cells damaged by lactacystin |
| Q38024220 | Recent preclinical evidence advancing cell therapy for Alzheimer's disease. |
| Q36368045 | Recombinant adeno-associated viral vectors as therapeutic agents to treat neurological disorders. |
| Q40202809 | Transplantation of human neural stem cells exerts neuroprotection in a rat model of Parkinson's disease. |
| Q45857411 | Vesicular monoamine transporter-2 and aromatic L-amino acid decarboxylase enhance dopamine delivery after L-3, 4-dihydroxyphenylalanine administration in Parkinsonian rats. |